
Medical technology firm Smith & Nephew has announced that chief executive Olivier Bohuon has been diagnosed with a ‘highly treatable …
Olivier Bohuon is leaving French pharma company Pierre Fabre after serving just five months as its chief executive. He will …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

